Admission to Trading
Summary by AI BETAClose X
5 June 2026
Dr. Martens plc ("the Company")
Notification of Admission of Further Securities to Trading (PRM 1.6.4R)
The following notification is made in accordance with PRM 1.6.4R.
|
1 |
Details of the issuer |
|
|
a) |
Name |
Dr. Martens plc |
|
b) |
LEI |
213800QPT8YM6NQZPH28 |
|
2 |
Details of the transferable securities admitted to trading |
|
|
a) |
Name, type and identification code |
Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 |
|
b) |
Regulated market |
London Stock Exchange - Main Market (XLON) |
|
c) |
Number of further securities issued and admitted |
623,983 |
|
d) |
Total number of securities in issue following admission |
967,943,542 |
|
e) |
Fungibility |
Fully fungible with existing Ordinary Shares |
|
3 |
Admission details |
|
|
a) |
Date(s) of admission |
20 January 2026 to 31 May 2026 (admitted under a block admission dated 12 December 2024 in connection with the Company's employee share schemes) |
|
b) |
Prospectus information |
N/A |
For further information, please contact:
Paul Rolling, Head of Secretariat
+447584243562
ENDS
About Dr. Martens
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot - named after the date it was produced - rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, "Docs" or "DM's" were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.
Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people. The company continues to honour the brand's heritage through its 'Made in England' footwear, manufactured at its original Northamptonshire factory, while meeting global demand from multiple high-quality production sites across Asia. All our products are made with an unwavering commitment to craft, combined with innovative techniques.
A brand built to put a bounce in the step of those who stand out from the crowd, Dr. Martens is available through Direct-to-Consumer (Retail and Ecommerce) and Wholesale channels. The brand's collections range from its Original silhouettes - The Icons such as the 1460 boot, 1461 shoe, 2976 Chelsea boot, and Adrian loafer - to modern franchises like the Zebzag, Buzz, and Lowell. The lineup also includes an extensive range of sandals, a dedicated Kids collection, and a curated selection of bags, small leather goods, and accessories.
Every Dr. Martens product reflects craftsmanship, heritage, timeless style, comfort, and versatility. Having transcended generations, the brand stays as relevant today as it was at its inception. Its signature yellow welt stitching, grooved sole edges, and scripted "With Bouncing Soles" heel loops remain iconic symbols recognised around the world.
Dr. Martens plc (DOCS.L) is listed on the main market of the London Stock Exchange and is a constituent of the FTSE 250 index.
For more information, visit www.drmartens.com or www.drmartensplc.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 4 hours ago Oxford Nanopore Technologies
- 5 hours ago AVI Global Trust
- 5 hours ago LSL Property Services
- 6 hours ago Bluebird Merchant Ventures (DI)
- 6 hours ago Power Probe PLC